Charles River Laboratories International, Inc.CRLNYSE
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P0
Near historical low
vs 5Y Ago
-15.5x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -608.17% |
| Q3 2025 | 4.01% |
| Q2 2025 | 105.45% |
| Q1 2025 | 111.81% |
| Q4 2024 | -414.07% |
| Q3 2024 | -23.68% |
| Q2 2024 | 33.65% |
| Q1 2024 | -64.01% |
| Q4 2023 | 114.08% |
| Q3 2023 | -9.93% |
| Q3 2023 | -5.93% |
| Q2 2023 | -44.97% |
| Q4 2022 | 94.26% |
| Q3 2022 | -11.75% |
| Q2 2022 | 17.52% |
| Q1 2022 | -32.39% |
| Q4 2021 | 33.02% |
| Q3 2021 | 16.93% |
| Q2 2021 | 43.75% |
| Q1 2021 | -57.03% |
| Q4 2020 | 39.14% |
| Q3 2020 | 52.60% |
| Q2 2020 | 32.83% |
| Q1 2020 | -36.81% |
| Q4 2019 | 10.35% |
| Q3 2019 | 66.51% |
| Q2 2019 | -20.69% |
| Q1 2019 | -7.60% |
| Q4 2018 | -1.16% |
| Q3 2018 | 12.40% |
| Q2 2018 | 2.05% |
| Q1 2018 | 276.32% |
| Q4 2017 | -156.88% |
| Q3 2017 | -2.74% |
| Q3 2017 | 15.34% |
| Q2 2017 | 4.70% |
| Q4 2016 | 18.40% |
| Q3 2016 | 7.18% |
| Q2 2016 | -5.21% |
| Q1 2016 | 16.49% |